Cite
HARVARD Citation
Zwicker, J. et al. (n.d.). Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor‐bearing microparticles: a randomized‐controlled phase II trial (the Microtec study). British journal of haematology. pp. 530-537. [Online].